LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

NCT04690699 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped business decision

Conditions

Solid Tumor
Bladder Cancer
Non-muscle-invasive Bladder Cancer

Interventions

BIOLOGICAL: Lerapolturev
OTHER: 5% DDM

Sponsor

Istari Oncology, Inc.